ZA200006020B - Voacamine as anti-malarial agent and anti-malarial agent containing voacamine. - Google Patents

Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.

Info

Publication number: ZA200006020B
Authority: ZA; South Africa
Prior art keywords: voacamine; malarial agent; malarial; agent containing; containing voacamine
Prior art date: 1998-03-26

Application number

ZA200006020A

Other languages

English (en)

Inventor

Silvio Rossi

Guiseppe Bertelli Motta

Original Assignee

Millenia Hope Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-26

Filing date

2000-10-26

Publication date

2001-06-25

2000-10-26 Application filed by Millenia Hope Inc filed Critical Millenia Hope Inc

2001-06-25 Publication of ZA200006020B publication Critical patent/ZA200006020B/xx

Links

239000003430 antimalarial agent Substances 0.000 title 2
VCMIRXRRQJNZJT-KANKAIPDSA-N methyl (1S,15R,17S,18S)-17-ethyl-6-[(1S,12R,14R,15Z,18S)-15-ethylidene-18-methoxycarbonyl-17-methyl-10,17-diazatetracyclo[12.3.1.03,11.04,9]octadeca-3(11),4,6,8-tetraen-12-yl]-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene-1-carboxylate Chemical compound CC[C@H]1C[C@H]2CN3CCC4=C(NC5=C4C=C(OC)C(=C5)[C@H]4C[C@@H]5[C@@H]([C@H](CC6=C4NC4=C6C=CC=C4)N(C)C\C5=C/C)C(=O)OC)[C@](C2)([C@H]13)C(=O)OC VCMIRXRRQJNZJT-KANKAIPDSA-N 0.000 title 2
229950009271 voacamine Drugs 0.000 title 2
KQFGPIYUBNBTND-UHFFFAOYSA-N voacamine Natural products CCC1CC2CN3CCc4c([nH]c5c(cc(OC)cc45)C6CC7C(C(Cc8c6[nH]c9ccccc89)N(C)C/C/7=CC)C(=O)OC)C(C2)(C13)C(=O)OC KQFGPIYUBNBTND-UHFFFAOYSA-N 0.000 title 2

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Tropical Medicine & Parasitology (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Medicines Containing Plant Substances (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Compounds Of Unknown Constitution (AREA)
Extraction Or Liquid Replacement (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

ZA200006020A 1998-03-26 2000-10-26 Voacamine as anti-malarial agent and anti-malarial agent containing voacamine. ZA200006020B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT98TO000264A ITTO980264A1 (it)	1998-03-26	1998-03-26	Applicazione di un estratto basico non quaternario della peschiera fuchsiaefolia ad attivita' antimalarica

Publications (1)

Publication Number	Publication Date
ZA200006020B true ZA200006020B (en)	2001-06-25

Family

ID=11416637

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200006020A ZA200006020B (en)	1998-03-26	2000-10-26	Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.

Country Status (10)

Country	Link
EP (1)	EP1067938A1 (fr)
JP (1)	JP2002507570A (fr)
AP (1)	AP2000001926A0 (fr)
AU (1)	AU2742799A (fr)
BR (1)	BR9909153A (fr)
CA (1)	CA2325879A1 (fr)
IT (1)	ITTO980264A1 (fr)
OA (1)	OA11491A (fr)
WO (1)	WO1999048501A1 (fr)
ZA (1)	ZA200006020B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2812199A1 (fr) *	2000-07-31	2002-02-01	Maximun Frederic Yanze	Nouvelles compositions pharmaceutiques effervescentes contenant la chloroquine
EP1491197A1 (fr) *	2003-06-26	2004-12-29	Bertelli Motta, Guiseppe	Composition pharmaceutique à base de voacamine pour la stimulation et modulation du système immunitaire humain
US20070232588A1 (en) *	2004-09-15	2007-10-04	Leonard Stella	Anti-parasitic and/or anti-viral and/or anti-microbial compositions
US20070032460A1 (en) *	2005-08-04	2007-02-08	Leonard Stella	Use of voacamine and related compounds in the treatment of malaria
US8188303B2 (en)	2005-10-04	2012-05-29	The Director General, Defence Research And Development Organisation	Anti-malarial compound isolated from Gomphostema niveum
EP1958638A1 (fr)	2007-02-14	2008-08-20	Polichem S.A.	Utilisation de chitosanes pour augmenter la vitesse de pousse des ongles
US20140303148A1 (en)	2011-11-28	2014-10-09	Industry-Academic Cooperation Foundation, Yonsei University	Pharmaceutical compositions for inhibiting angiogenesis comprising plant-derived natural compound
EP2934541A4 (fr) *	2012-12-20	2016-08-03	Demerx Inc	Noribogaïne substituée
GB2571696B (en)	2017-10-09	2020-05-27	Compass Pathways Ltd	Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en)	2017-10-09	2025-11-04	Compass Pathfinder Limited	Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
AU2020258086A1 (en)	2019-04-17	2021-11-11	Compass Pathfinder Limited	Methods of treating neurocognitive disorders, chronic pain and reducing inflammation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2823204A (en) *	1956-03-30	1958-02-11	Gobey Lab	Alkaloids of voacanga

1998
- 1998-03-26 IT IT98TO000264A patent/ITTO980264A1/it unknown
1999
- 1999-03-25 CA CA002325879A patent/CA2325879A1/fr not_active Abandoned
- 1999-03-25 BR BR9909153-4A patent/BR9909153A/pt not_active Application Discontinuation
- 1999-03-25 AP APAP/P/2000/001926A patent/AP2000001926A0/en unknown
- 1999-03-25 AU AU27427/99A patent/AU2742799A/en not_active Abandoned
- 1999-03-25 WO PCT/IB1999/000524 patent/WO1999048501A1/fr not_active Ceased
- 1999-03-25 JP JP2000537549A patent/JP2002507570A/ja active Pending
- 1999-03-25 EP EP99907808A patent/EP1067938A1/fr not_active Withdrawn
2000
- 2000-09-22 OA OA1200000261A patent/OA11491A/en unknown
- 2000-10-26 ZA ZA200006020A patent/ZA200006020B/xx unknown

Also Published As

Publication number	Publication date
OA11491A (en)	2004-05-07
EP1067938A1 (fr)	2001-01-17
JP2002507570A (ja)	2002-03-12
WO1999048501A9 (fr)	2000-03-16
WO1999048501A1 (fr)	1999-09-30
AP2000001926A0 (en)	2000-09-30
BR9909153A (pt)	2000-11-14
AU2742799A (en)	1999-10-18
CA2325879A1 (fr)	1999-09-30
ITTO980264A1 (it)	1999-09-26

Publication	Publication Date	Title
PL352468A1 (en)	2003-08-25	Atherapeutic agent containing botuline neurotoxin
ZA991951B (en)	1999-08-16	Compound and its use.
ZA200110022B (en)	2003-05-28	Thiazoloderivatives and pharmaceutical compositions containing them.
HUP0103884A3 (en)	2002-11-28	Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use
ZA200107870B (en)	2002-09-25	Fused-ring compounds and use thereof.
GB9712317D0 (en)	1997-08-13	Composition, compound and use
PL351250A1 (en)	2003-04-07	Antipicornaviral compounds, their preparation and use
GB9817235D0 (en)	1998-10-07	Compound,composition and use
PL332616A1 (en)	1999-10-25	Hydoxymethylhexanones as odorising and savourising agents
EP1056455A4 (fr)	2000-12-06	Compose d'epimorphine et utilisation de ce dernier
GB9817236D0 (en)	1998-10-07	Compound,composition and use
GB9718876D0 (en)	1997-11-12	Compound,composition and use
ZA200006020B (en)	2001-06-25	Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.
GB9923344D0 (en)	1999-12-08	Foams and compositions containing these foams
GB9903447D0 (en)	1999-04-07	Compound, composition and use
ZA200109989B (en)	2003-02-26	Pharmaceutical composition containing sibutramine and orlistat.
ZA987483B (en)	1999-05-21	Contrast agent
GB9817238D0 (en)	1998-10-07	Compound,composition and use
GB9917593D0 (en)	1999-09-29	Compound, composition, process and use
GB9723859D0 (en)	1998-01-07	Compound,composition and use
ZA991761B (en)	1999-09-06	New agent.
ZA200109120B (en)	2003-11-13	Use of Arylalkanoylpyridazines.
HUP0103006A3 (en)	2002-12-28	Substituted betha-diketones, pharmaceutical compositions containing them and their use
AP9901651A0 (en)	1999-09-30	Nitro-benzamide useful as anti-arrhytmic agent
GB9723853D0 (en)	1998-01-07	Compound, composition and use